BGICC25 Updates: Dr. Mansoor Raza Mirza on Endometrial Cancer Advances
The 17th BGICC (Breast Gynecological and Immunooncology International Cancer Conference) was held on 23rd-24th January 2025 at the Hilton Heliopolis Hotel in Cairo, Egypt. This conference, recognized as the largest and most prestigious cancer event in Africa and the Middle East, served as a major platform for discussing the latest updates and trends in breast and gynecological cancers.
Under the slogan “Illumination and Creation,” it also highlighted advancements in genetics and immuno-oncology, covering all oncology aspects from diagnosis to future innovations. The event featured a range of scientific and educational symposia, workshops, debates, and recommendation sessions, with collaborations from world-renowned scientists and esteemed societies.
Dr. Mansoor Raza Mirza, a clinical oncologist from Copenhagen University Hospital, joins OncoDaily at BGICC 2025 to share insights on the role of immunotherapy in endometrial cancer. He discusses the transformative impact of immune checkpoint inhibitors, supported by phase 3 trial data from the RUBY and DUO-E studies, in improving survival rates for patients with mismatch repair-deficient tumors.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023